You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 13, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 9, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 4 days later
UTHR daily price context
Close on/before transaction
$549.16
Oct 9, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000161
Filing cohort
Transactions in this filing
Showing 15 of 19
Trades
19
Issuers
1
Estimated value
$6.3M
Buys / sales
0 / 17
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $342.27K |
| United Therapeutics Corp UTHR | Exercise | Oct 9, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $215.33K |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $107.85K |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $173.04K |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $21.66K |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $217.82K |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $218.36K |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $131.18K |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $481.15K |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $1.45M |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $812.8K |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $232.95K |
| United Therapeutics Corp UTHR Current | Exercise | Oct 9, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Oct 9, 2026 | $170.82K |